PHAT
Phathom Pharmaceuticals
$11.95
+$0.51 (+4.46%)Jul 27, 2026
Key metrics
The numbers that frame PHAT today
- Market cap
- $953.08M
- P/E (TTM)
- -6.1
- EV / FCF
- -13.1
- Gross margin
- 84.9%
- EV / Sales
- 6.3
- ROIC
- -16.7%
- Div yield
- 0%
- 52wk Low
- $8.03
- 52wk High
- $18.31
Growth
Revenue and earnings trend for PHAT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PHAT
Is Phathom Pharmaceuticals a good buy?
No. Phathom Pharmaceuticals has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Phathom Pharmaceuticals is selling at a high price.
What is the market capitalization of PHAT?
Phathom Pharmaceuticals's market capitalization is $953.08M.
What is the P/E ratio for PHAT stock?
Phathom Pharmaceuticals's current P/E ratio is -6.1.
What is the 52-week high for PHAT stock?
The 52-week high for Phathom Pharmaceuticals is $18.31. The current close of $11.95 is 34.7% below that high.
What is the 52-week low for PHAT stock?
The 52-week low for Phathom Pharmaceuticals is $8.03. The current close of $11.95 is 48.9% above that low.
Does PHAT stock pay dividends?
Phathom Pharmaceuticals does not currently show a dividend per share in the company data.